Scientific article

Quality assessment of the visits of pharmaceutical company representatives to hospital pharmacists

Published inSchweizerische medizinische Wochenschrift, vol. 135, no. 45-46, p. 666-673
Publication date2005

OBJECTIVES: To evaluate whether the quality of pharmaceutical company representatives' (PCRs) visits to hospital pharmacists can be improved by written communication of the results of an evaluation of their visits. METHODS: Pilot study with prospective evaluation of overall visit quality and strength of request for adding drugs to the hospital formulary, and of the scientific quality of products presentations using a standardized form. Two one-year study periods (59 vs. 61 visits) separated by the intervention (global results of the first period sent to each drug company). RESULTS: No difference was observed between both periods in overall visit quality (VAS 0 = null, 10 = excellent: mean 4.7 (2.1 SD) vs. 5.2 (2.1) or strength of request for adding drug to hospital formulary (VAS 0 = null, 10 = extreme: 7.0 [2.6] vs. 7.2 [2.7]). Clarity and scientific value of products' presentations and scientific value of responses were better during the second study period, as a sign of quality improvement. CONCLUSIONS: This study suggests that systematic quality evaluation of PCRs visits and communication of results to drug companies may improve the scientific quality of products' presentation.

Citation (ISO format)
FONZO-CHRISTE, Caroline Cécile, HERRMANN, François, BONNABRY, P. Quality assessment of the visits of pharmaceutical company representatives to hospital pharmacists. In: Schweizerische medizinische Wochenschrift, 2005, vol. 135, n° 45-46, p. 666–673.
Main files (1)
ISSN of the journal0036-7672

Technical informations

Creation05/28/2013 3:42:53 PM
First validation05/28/2013 3:42:53 PM
Update time03/14/2023 8:16:18 PM
Status update03/14/2023 8:16:18 PM
Last indexation02/12/2024 8:28:20 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack